Trials / Unknown
UnknownNCT02802644
The Effect of DPP4 Inhibitor on Vasclular Healing
A Prospective, Multi-center, Randomized, Controlled Study to Evaluate the Effect of DiPeptidyl-Peptidase 4 Inhibitor on Vascular Healing After Biodegradable Polymer Based Sirolimus Eluting Stent Implantation in Diabetic Patients: OCT Study (DIAMOND-OCT)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Chung-Ang University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluate the effect of dipeptidyl-peptidase 4 inhibitor on vascular healing after biodegradable polymer based sirolimus eluting stent implantation in diabetic pateints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sitagliptin | Sitagliptin is indicated to control hyperglycemia in type 2 diabetic patients. |
| DRUG | Non DPP-4 Inhibitor | This group patients is permitted to take any other oral anti-hyperglycemic agents except sitagliptin. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-06-01
- First posted
- 2016-06-16
- Last updated
- 2016-06-16
Locations
6 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02802644. Inclusion in this directory is not an endorsement.